Axsome Therapeutics Stock Forecast - Period Momentum Indicator

AXSM Stock  USD 97.84  0.98  0.99%   
Axsome Stock Forecast is based on your current time horizon. Although Axsome Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Axsome Therapeutics' systematic risk associated with finding meaningful patterns of Axsome Therapeutics fundamentals over time.
  
At this time, Axsome Therapeutics' Payables Turnover is very stable compared to the past year. As of the 11th of December 2024, Fixed Asset Turnover is likely to grow to 43.62, while Inventory Turnover is likely to drop 1.17. . As of the 11th of December 2024, Common Stock Shares Outstanding is likely to drop to about 30.1 M. In addition to that, Net Loss is likely to grow to about (160 M).
On December 2, 2024 Axsome Therapeutics had Period Momentum Indicator of (1.24). Momentum indicator evaluates the difference between todays closing price and the close price n periods ago. It is the velocity with which the price is rising or falling. It also reflects how aggressively the asset is purchased or sold by the public.
Check Axsome Therapeutics VolatilityBacktest Axsome TherapeuticsTrend Details  

Axsome Therapeutics Trading Date Momentum

On December 03 2024 Axsome Therapeutics was traded for  100.49  at the closing time. The top price for the day was 102.00  and the lowest listed price was  99.00 . The trading volume for the day was 587 K. The trading history from December 3, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 1.42% . The overall trading delta against the current closing price is 1.14% .
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
Compare Axsome Therapeutics to competition

Other Forecasting Options for Axsome Therapeutics

For every potential investor in Axsome, whether a beginner or expert, Axsome Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Axsome Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Axsome. Basic forecasting techniques help filter out the noise by identifying Axsome Therapeutics' price trends.

View Axsome Therapeutics Related Equities

 Risk & Return  Correlation

Axsome Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Axsome Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Axsome Therapeutics' current price.

Axsome Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Axsome Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Axsome Therapeutics shares will generate the highest return on investment. By undertsting and applying Axsome Therapeutics stock market strength indicators, traders can identify Axsome Therapeutics entry and exit signals to maximize returns.

Axsome Therapeutics Risk Indicators

The analysis of Axsome Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Axsome Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting axsome stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Axsome Therapeutics is a strong investment it is important to analyze Axsome Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Axsome Therapeutics' future performance. For an informed investment choice regarding Axsome Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Axsome Therapeutics to cross-verify your projections.
To learn how to invest in Axsome Stock, please use our How to Invest in Axsome Therapeutics guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axsome Therapeutics. If investors know Axsome will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axsome Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.58)
Revenue Per Share
7.108
Quarterly Revenue Growth
0.813
Return On Assets
(0.26)
Return On Equity
(1.72)
The market value of Axsome Therapeutics is measured differently than its book value, which is the value of Axsome that is recorded on the company's balance sheet. Investors also form their own opinion of Axsome Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Axsome Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axsome Therapeutics' market value can be influenced by many factors that don't directly affect Axsome Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axsome Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Axsome Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axsome Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.